The purpose of the study is to examine the effectiveness of mifepristone treatment in
patients with refractory depression. Refractory depression is defined as clinical depression
that is unimproved after treatment with at least 2 different antidepressants of adequate dose
and time trial. Mifepristone will augment current medications.